We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma (RAD001)

This study has been terminated.
(delayed recruitment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00933374
First Posted: July 7, 2009
Last Update Posted: March 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Heinrich-Heine University, Duesseldorf
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)